PMV Capital Advisers’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.1M Sell
188,303
-58,318
-24% -$709K 3.15% 10
2026
Q1
$3.44M Buy
246,621
+30,234
+14% +$424K 5.81% 4
2025
Q4
$3.11M Buy
216,387
+11,624
+6% +$175K 5.67% 5
2025
Q3
$3.26M Buy
204,763
+53,603
+35% +$883K 6.33% 4
2025
Q2
$2.68M Buy
151,160
+17,455
+13% +$340K 5.96% 4
2025
Q1
$2.79M Buy
133,705
+129,935
+3,447% +$2.46M 6.77% 3
2024
Q4
$69.7K Buy
+3,770
New +$72.5K 0.19% 33

Other funds holding BTAL

PMV Capital Advisers's BTAL Position: Q2 2026 in Review

PMV Capital Advisers reduced its AGF US Market Neutral Anti-Beta Fund (BTAL) stake by 24% in Q2 2026, selling an estimated $709K and leaving 188,303 shares worth $2.1M. The position accounts for 3.15% of the portfolio, ranked #10.

PMV Capital Advisers first reported a position in BTAL in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.44M in Q1 2026. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • PMV Capital Advisers held 188,303 shares of AGF US Market Neutral Anti-Beta Fund worth $2.1M as of Q2 2026.
  • PMV Capital Advisers sold 58,318 AGF US Market Neutral Anti-Beta Fund shares in Q2 2026, an estimated $709K.
  • AGF US Market Neutral Anti-Beta Fund made up 3.15% of PMV Capital Advisers's portfolio in Q2 2026, its #10 holding.
  • PMV Capital Advisers first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2024 and has held it in 7 quarters since.
  • PMV Capital Advisers's AGF US Market Neutral Anti-Beta Fund position peaked at $3.44M in Q1 2026.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on PMV Capital Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.